INTRODUCTION {#sec1-1}
============

Dental caries still remains one of the most common diseases worldwide, although a decline of the prevalence has been recorded in western countries.\[[@ref1]\] It is an endogenous disease that results from a homeostatic imbalance between the host and microbiota.\[[@ref2]\] Research indicates a multispecies etiology for dental caries, the mutans streptococci (MS), a cluster of acidogenic, dental plaque-inhabiting streptococcal species, are still recognized as major constituents of most active dental caries lesions.\[[@ref3]\]

Caries management strategies have traversed through various paths and are now witnessing a paradigm shift toward preventive approach. The genesis of a dental carious lesion is determined by the interplay of multiple factors.\[[@ref4]\] This interplay is best explained by the Keyes' triad Venn diagram proposed in the 1960s which includes tooth, diet, and dental plaque.\[[@ref5]\] Enhancing the inherent defense mechanism of saliva and diminishing the microbial levels seems to be a rational approach. Treatments using antistreptococcal antimicrobials can be effective in the short term to reduce dental plaque levels and to decrease counts of MS, but, as most therapeutic antibiotics have relatively broad-spectrum antimicrobial activity, they indiscriminately destroy both commensal as well as the potentially destructive bacteria, and thereby create population imbalances within the microflora.\[[@ref3]\]

Therefore, recent studies aim to identify methods that would selectively inhibit oral pathogens rather than the whole microbial community.\[[@ref6]\] One such approach currently researched extensively is the use of probiotics. The application of oral probiotics to help reinstate a balanced microbiota and thereby improving oral health is relatively a new concept. Probiotics are beneficial bacteria that can improve the microecological balance of the host.\[[@ref7]\] They confer a health benefit to the host when administered in adequate amounts.\[[@ref8]\] Most probiotics are Gram-positive bacteria that belong to the genera *Lactobacillus* or *Bifidobacterium*.\[[@ref9]\] Studies based on the use of the intestinal probiotics *Lactobacillus rhamnosus* GG,\[[@ref10]\] *Lactobacillus reuteri*, and *Bifidobacterium*\[[@ref11]\] have each reported achieving reduced levels of *Streptococcus mutans*. However, these strains have limitations in terms of their colonization of oral tissues.

Hence, a new generation of probiotic strains sourced from the human oral cavity and belonging to commensal species known to have extremely low pathogenic potential has more recently been developed.\[[@ref12]\] *Streptococcus thermophilus* was found to be an effective probiotic for oral health.\[[@ref13][@ref14]\] *Streptococcus salivarius*, a Gram-positive bacterium, is currently being used as a oral probiotic. Two of the most commonly used *S. salivarius* strains are K12 and M18.\[[@ref12]\] *S. salivarius* strain JH has also been reported to have a potent anti-MS activity.\[[@ref15]\]

The aim of this article is to review the published literature with the purpose of knowing the importance of using various probiotic *Streptococcus* strains as a preventive and therapeutic method for dental caries management. The hypothesis behind this systematic review was that the administration of probiotic *Streptococcus* strains might play a role in the carious lesion incidence.

MATERIALS AND METHODS {#sec1-2}
=====================

Structured question {#sec2-1}
-------------------

Among people with and without dental caries, do probiotic *Streptococcus* strains have an action against carious incidence?

PICO analysis {#sec2-2}
-------------

Population -- people with and without dental cariesIntervention -- probiotic *Streptococcus* strainsOutcome -- reduction in microbial count, reduction in new carious lesion, decreased caries risk in cariogram.

Inclusion and exclusion criteria {#sec2-3}
--------------------------------

### Inclusion criteria {#sec3-1}

Studies were included if they focused on the use of probiotic *Streptococcus* strains for caries prevention. Only original research published in journals was included in this review. Articles published in English alone were included. Only studies in English were collected, due to the virtual absence of research published in other languages.

### Exclusion criteria {#sec3-2}

All *in vitro* studies and *in vivo* studies not focusing on administration of probiotic *Streptococcus* species for caries prevention and studies where probiotic *Streptococcus* species were administered for other reasons were excluded. Systematic reviews and meta-analysis were also excluded from the review.

Search strategies {#sec2-4}
-----------------

Electronic literature search was conducted across PubMed/Medline, Scopus, EBSCOhost, Embase, and ScienceDirect databases. Two preliminary searches were conducted in January 2018 to obtain an overall idea of findings and to polish search terms (MeSH words) and limits. The MeSH Browser was accessed to identify entry terms and compose the final Boolean searches. First, the MeSH terms Dental Caries and Probiotic(s) were associated following which, a combination of keywords derived from the two previous MeSH terms were searched. The keywords used were probiotics dental caries, oral cavity, and probiotic streptococci. [Table 1](#T1){ref-type="table"} shows the keywords and search strategy used through the databases. A comparison of the 22 different searches was carried out to delete the repeated studies. All papers published from 1989 to December 2017 were considered for the present review. Abstracts of all selected papers were examined independently by two different evaluators. All studies, which appeared to meet the inclusion and exclusion criteria, were obtained in the full-text format.

###### 

The keywords and search strategy through the databases

  Keywords                                                                                                                                                                 PubMed   Scopus   EBSCOhost   Embase   Science direct
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------- -------- ----------- -------- ----------------
  Probiotics, probiotic, dental caries, oral cavity, probiotic streptococci Search string ((((probitoics) OR probiotic)) AND (((dental caries) OR oral cavity) OR oral))   2630     1457     1325        1232     1863

###### 

The full electronic search strategy for PubMed database

  Search string                                                                           No of articles listed
  --------------------------------------------------------------------------------------- -----------------------
  Search (dental caries) OR oral cavity                                                   410,300
  Search (probiotics) OR probiotic                                                        20,475
  Search ((((probiotics) OR probiotic)) AND (((dental caries) OR oral cavity) OR oral))   2630

Study selection {#sec2-5}
---------------

Two trained and calibrated reviewers (P. S, N. M. S) independently screened the title and abstract of the selected articles by applying the above-mentioned inclusion and exclusion criteria. Full-text articles were read completely to validate inclusion into the systematic review. Disagreements were settled by discussion with a third reviewer (M. R. S).

Data extraction {#sec2-6}
---------------

Selected articles were read independently by the two reviewers to extract data (P. S, N. M. S). Studies were divided into four types of study design: clinical trials and *in vitro* studies. [Table 2](#T2){ref-type="table"} describes the information extracted from each type of paper. Disagreements between the two reviewers were resolved by discussion with a third reviewer (M. R. S).

###### 

The data extracted from each type of study design

  -------------------------------------------------------------------------------
  Clinical trials                               *In vitro* studies
  --------------------------------------------- ---------------------------------
  Author\                                       Author\
  Year\                                         Year\
  Number of participants completed the trial\   Model used\
  Probiotic strains\                            Carious strains\
  Control used\                                 Probiotic strains\
  Probiotic form\                               Outcomes assessed\
  Probiotic dosage\                             Methods used to assess outcome\
  Outcomes assessed\                            Results
  Results                                       

  -------------------------------------------------------------------------------

Quality assessment of included studies {#sec2-7}
--------------------------------------

Each study was assessed using the evaluation method described in the Cochrane Handbook for Systematic Reviews.\[[@ref16]\] The risk of bias was assessed individually for selection bias, performance bias, detection bias, attrition bias, and reporting bias. Each domain was classified as having a low, high, or unclear risk of bias.

To analyze the methodological quality of *in vitro* studies, the clinical appraisal checklist for *in vitro* studies by Faggion\[[@ref17]\] was carefully analyzed and modified to include all relevant contents relating to the methodology based on the research question and PICOS structure. Two authors (P. S, N. M. S) independently scored the articles, and in case of disagreement, consensus was reached with the help of third author (M. R. S). The level of evidence of each article was rated based on the scoring points: low (score 0--4), moderate (score 5--9), and high (score 10--14).

RESULTS {#sec1-3}
=======

The complete search process used in our systematic review is shown in [Figure 1](#F1){ref-type="fig"}. The number of articles identified from electronic databases is listed in [Table 1a](#T1){ref-type="table"}. [Table 1b](#T6){ref-type="table"} shows the full electronic search strategy for PubMed database. A total of 2630 articles meeting the inclusion criteria were identified from the initial search after removing duplicates. Among these, 2504 articles were excluded based on the exclusion criteria. After screening the title and abstract of the remaining 126 articles, 118 articles were excluded as they were found to be irrelevant. The full text of the remaining eight articles was obtained. From this, three papers were excluded as they did not meet the inclusion criteria. A total of five papers were included in the systematic review.

![Briefly showing the search process in this systematic review](JCD-22-123-g001){#F1}

Among the five papers included in this systematic review, two were clinical trials\[[@ref3][@ref12]\] and three were *in vitro* studies.\[[@ref15][@ref18][@ref19]\] The basic characteristics of the included studies are presented in Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}. Both the included clinical trials compared *S. salivarius* M18 with the control. In the included studies, differences were observed in the following aspects: (a) form of probiotic, (b) probiotic dosage, and (c) outcomes assessed. Among the three *in vitro* studies included, thought the carious strains used were similar, differences were observed in (a) probiotic strains used, (b) outcomes assessed, and (c) methods used for outcome assessment.

###### 

The characteristics of included clinical trials

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                           Year   Number of participants the completed trial   Control        Probiotic strains       Probiotic form            Probiotic dosage                   Outcomes assessed                                                                                                           Results
  -------------------------------- ------ -------------------------------------------- -------------- ----------------------- ------------------------- ---------------------------------- --------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------
  Di Pierro *et al*.\[[@ref12]\]   2015   40 (probiotic)\                              Placebo        *S*. *salivarius* M18   Lozenges                  2 lozenges each day for 3 months   Cariogram Outcome                                                                                                           Use of *salivarius* M18 increases the chances of avoiding new dental caries development in children
                                          43 (placebo)                                                                                                                                                                                                                                                                 

  Burton *et al*.\[[@ref3]\]       2013   38 (treated group)\                          No treatment   *S*. *salivarius* M18   Dissolving oral tablets   Once a day for 3 months            Salivary levels of *S. salivarius*, *S. mutans*, *lactobacilli*, b-hemolytic streptococci, and *Candida* species assessed   Cell-culture analyses of sequential saliva samples showed no differences reduced *S. mutans* counts
                                          38 (control group)                                                                                                                                                                                                                                                           
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

S. mutans: Streptococcus mutans, S. salivarius: Streptococcus salivarius

###### 

The characteristics of *in vitro* studies included

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                             Year   Model Used      Carious strains               Probiotic Strains        Outcomes assessed                     Methods used                                                         Results
  ---------------------------------- ------ --------------- ----------------------------- ------------------------ ------------------------------------- -------------------------------------------------------------------- ---------------------------------------------------------------------------------
  Schwendicke *et al*.\[[@ref18]\]   2017   Biofilm         SM ATCC 25175 SM ATCC 20532   *Streptococcus* (TH-4)   Zone of inhibition of SM\             Agar diffusion method\                                               Strong inhibitory effect on *S*. *mutans* growth\
                                                                                                                   Biofilm formation inhibition\         Transverse microradiography\                                         Reduced SM numbers in biofilms than in monospecies\
                                                                                                                   Enamel mineral loss\                  Quantified on BHI agar                                               Mineral loss by SM×LA-5 biofilms was higher than monospecies\
                                                                                                                   Biofilm bacterial numbers                                                                                  Bacterial numbers least in monospecies biofilm and highest in mixed species

  Walker *et al*.\[[@ref15]\]        2016   Not mentioned   SM ATCC 25175                 *S. salivarius* JH       *S. mutans* inhibitory activity       Testing dextranase and BLIS activity                                 Increased anti-*S. mutans* activity

  Lee and Kim\[[@ref19]\]            2014   Biofilm         *S. gordonii* ATCC 10558\     *S. thermophilus*        Antimicrobial activity\               Kirby-Bauer disk diffusion Petroff-Hausser counting chamber RT-PCR   *Lactobacillus* strains formed wider bacteria free zones than *S. thermophilus*
                                                            S. oralis ATCC 9811\                                   Bacterial count\                                                                                           
                                                            *S. sanguinis* 804\                                    Quantify changes in GTFS expression                                                                        
                                                            *S. mutans* ATCC 25175                                                                                                                                            
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BHI: Brain-heart infusion, *S. salivarius: Streptococcus salivarius, S. mutans: Streptococcus mutans, S. thermophiles: Streptococcus thermophiles, S. gordonii: Streptococcus gordonii*, RT-PCR: Real-time polymerase chain reaction

A total of two clinical trials and three *in vitro* were assessed for the risk of bias. Figure [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"} shows the risk of bias of included clinical trials. The level of evidence of the included *in vitro* articles has been presented in [Table 5](#T5){ref-type="table"}. The overall risk of bias of the selected clinical trials was found to be high risk, and the overall level of evidence of the selected *in vitro* studies was moderate. In both the clinical trials, patients were not subjected to randomization and blinding. Overall, there was a lack of data on the sample size calculation and information on the incidence of any adverse events.

![Risk of bias summary: review authors' judgements about each risk of bias item for each included study](JCD-22-123-g002){#F2}

![Risk of bias graph depicting each risk of bias item presented as percentages across all included studies](JCD-22-123-g003){#F3}

###### 

The level of evidence for the*in vitro* studies included

  Study                              Level of evidence
  ---------------------------------- -------------------
  Schwendicke *et al*.\[[@ref18]\]   Moderate
  Walker *et al*.\[[@ref15]\]        Moderate
  Lee and Kim\[[@ref19]\]            Moderate

DISCUSSION {#sec1-4}
==========

Recent clinical studies have shown that specific probiotic strains can affect oral pathogens by reducing the counts of *S. mutans* and lactobacilli in the saliva and biofilm.\[[@ref20][@ref21]\] Conventional probiotics typically comprised bacteria from intestinal origin (especially lactobacilli and bifidobacteria). However, the realization that oral diseases such as dental caries, periodontal disease, and candidosis can be directly linked to the development of oral microbiota disequilibria has diverted the contemporary probiotic research to the development of products that are capable of establishing a healthy oral microbiota.\[[@ref22]\] The antimicrobial action of probiotics can be attributed to their ability to produce lactic and acetic acids that diminish the pH of the medium. These bacteria compete with the pathogenic strains for nutrient sources, releasing hydrogen peroxide and bacteriocins, an action to that of the antibiotics.\[[@ref23]\] The mechanism involved is that the undissociated form of the organic acid enters the bacterial cell and dissociates inside the cytoplasm. Lowering of the intracellular pH or the intercellular accumulation of the ionized form of the organic acid leads to death of the pathogen.\[[@ref24]\]

The scientific origin of oral probiotics can be traced to the use of mixtures of putative oral commensals producing incompletely characterized inhibitory agents against *Streptococcus pyogenes* or otitis media pathogens.\[[@ref25][@ref26]\] An alternative approach was to target the mutans streptococci using an ultracompetitive bacteriocin-producing *S. mutans*, genetically modified to attenuate its virulence.\[[@ref27]\] Literature search revealed that there was deficiency in research examining the effects of these probiotic Streptococcal strains on salivary microflora. Thus, the role of the probiotic streptococcal strains in caries prevention was the main focus of this systematic review. Results described by various research groups were encouraging, but the scientific evidence is still unclear, and the level of evidence is only moderate. The articles reviewed reported high risk of bias and moderate level of evidence, which limited the conclusions about the real efficacy of various strains of probiotic *Streptococcus* sps administration in caries lesion prevention.

Among the articles included, *S. thermophilus* has been probiotic strain of choice in two of the *in vitro* studies.\[[@ref18][@ref19]\] Schwendicke *et al*.\[[@ref18]\] found *S. thermophilus* to have comparably limited SM growth inhibition and SM biofilm formation inhibition capabilities. It is a relevant probiotic for oral health, as it is aciduric by way of its urease activity, which increases in acidic environments.\[[@ref13][@ref14]\] This could allow *S. thermophilus* to replace other cariogenic species (like lactobacilli) from oral biofilms, thus decreasing their cariogenicity. In contrary, Lee and Kim\[[@ref19]\] in his study showed that *Lactobacillus* strains formed wider bacteria free zones than *S. thermophilus*.

Another Streptococcal species that is utilized as a commercial oral probiotic of particular importance and the subject of extensive research is *S. salivarius*. This species is a spherical, Gram-positive, oxidase-negative, and catalase-negative bacterium. *S. salivarius* is one of the earliest colonizers of the epithelial lining of the human mouth and nasopharynx. The bacterium colonizes the tongue dorsum and pharyngeal mucosa of infants, who acquire the bacterium from their mother within 2 days after birth. The two most well-studied strains of *S. salivarius* that are currently employed as probiotics are strains K12 and M18. *S. salivarius* K12 was first isolated from the saliva of a healthy child and has been utilized as a commercial probiotic in New Zealand for over a decade. Clinical trials included in this review\[[@ref3][@ref12]\] evaluated the influence of probiotic *S. salivarius* M18 on the reduction of caries risk.\[[@ref28][@ref29][@ref30]\] Burton *et al*.\[[@ref3]\] in their study demonstrated that twice daily dosing with Streptococcus salivarius M18 is an effective way of reducing plaque formation in schoolchildren. The results of the study by Di Pierro *et al*.\[[@ref12]\] showed that the use of *S. salivarius* M18 increases the chance of avoiding new caries development in children.

Walker *et al*.\[[@ref15]\] in his study showed that oral probiotic *S. salivarius* JH produces important *in vitro* inhibitory activity toward strains of *S. mutans* and *Streptococcus sobrinus*, the principal species of MS associated with human dental caries. As stated by him, this anti-MS activity appears, at least in part, attributable to the production of SalE, a newly described bacteriocin. Strain JH has also been demonstrated to produce the EPS-hydrolyzing enzyme, dextranase, in larger amounts. Findings of his study indicate that exposure of biofilms to EPS-hydrolyzing enzymes such as dextranase may increase the matrix penetration and killing efficacy of some antibacterial agents. Due to its relatively broad inhibitory spectrum toward oral pathogenic bacteria, and *in vitro* production of unusually high levels of dextranase activity by strain JH, Walker *et al*.\[[@ref15]\] recommended that the probiotic potential of this strain was further investigated with human subjects.

The current systematic review has shown the lack of clinical research pertaining to the use of probiotic streptococcal strains in caries prevention. As there is paucity of clinical research in this field, the focus of future studies should be on the evaluation of the effect of various streptococcal strains on plaque formation, on modulation of the composition of the oral microbiota and their influence on caries risk. There should be more emphasis on any changes in the mutans streptococcal populations of the host. Further clinical research is vital to recognize specific strains with probiotic activity and also to determine the exact dose, treatment time, and ideal vehicles. The main limitation of this systematic review is that studies in English were only included. Furthermore, the search was confined to specific search engines.

CONCLUSION {#sec1-5}
==========

Within the limitations of the systematic review, it can be concluded that, the two included clinical studies on the use of probiotic *Streptococcus* strains for caries prevention had high risk of bias. Although in-vitro studies showed promising results, clinical studies have not demonstrated clear clinical outcomes. As the scientific evidence in this regard is still poor, well-designed high-quality clinical research is required to improve the level of evidence in this area of research.
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